Search details
1.
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.
Lancet
; 401(10373): 281-293, 2023 01 28.
Article
in English
| MEDLINE | ID: mdl-36566761
2.
Cost-utility analysis of molnupiravir plus usual care versus usual care alone as early treatment for community-based adults with COVID-19 and increased risk of adverse outcomes in the UK PANORAMIC trial.
Br J Gen Pract
; 2024 Jan 16.
Article
in English
| MEDLINE | ID: mdl-38228357
Results
1 -
2
de 2
1
Next >
>>